| CEO Name | Huw Hughes |
| Nationality | United Kingdom |
| Net Worth Estimation | $2 million |
Huw Hughes, CEO of Norbrook Laboratories, has an estimated net worth of around $2 million, derived from executive compensation, performance bonuses, and equity holdings within the privately-owned pharmaceutical company. His wealth is modest compared to the global pharmaceutical sector due to Norbrook's private ownership and the Hughes family's retained majority control.
Huw Hughes, CEO of Norbrook Laboratories, has an estimated net worth of $2,000,000, which represents 2.86% of the maximum estimated net worth ($70,000,000) for CEOs in the veterinary business category. His net worth is double the category's minimum estimate of $1,000,000.
Business Category: Veterinary
Minimum Net Worth (estimation): 1000000 USD
Maximum Net Worth (estimation): 70000000 USD
Huw Hughes Performance in Norbrook Laboratories
Huw Hughes, CEO of Norbrook Laboratories, demonstrates strategic leadership by driving innovation and expanding global market presence. His decisive approach to decision-making emphasizes operational efficiency and sustainable growth. Under his leadership, Norbrook has strengthened its pharmaceutical portfolio, enhancing company performance and solidifying its industry reputation.
Latest News
Norbrook Laboratories recalls, CEO changes, and strategic growth updates
Norbrook Laboratories faced a major product recall in 2024, impacting sales and profits significantly. Liam Nagle, who led the company for years, was succeeded by Andrea Iucci as CEO in late 2023, but Iucci resigned in mid-2025, with Nagle stepping back as executive chair during the transition. Despite challenges, Norbrook reported resilient growth initiatives in 2024, including new product launches and operational investments.
Source: http://www.pharmatrax.pk/a-major-recall-of-dozens-of-veterinary-injectable-drug-products-earlier-this-year-by-norbrook-laboratories-has-wiped-millions-of-pounds-off-its-bottom-line-latest-accounts-reveal/